Skip to content

Synthetic Seeding Spacer (SS9 X 50-50 +3 more) - SS9 X 55-50

by Biocompatibles, Inc.

510(k) K100847

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK100847 Date21 May 2010ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
KXK
Models / Variants
SS9 X 55-50
Device Class
Class II
Regulation
21 CFR Part 892.5730
Advisory Committee
Radiology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Synthetic Seeding Spacer Model SS9 is a brachytherapy device designed to create and maintain spacing between radionuclide seeds during implantation procedures. It is intended for use in radiology applications to ensure proper seed distribution within the target tissue, aiding in precise radiation delivery for cancer treatment.

These spacers are single-use, non-sterile devices supplied in sterile packaging for clinical use. They are classified as Class II medical devices under FDA regulation 892.5730 and were granted 510K clearance by the FDA in 2010. Available in multiple sizes (SS9 X 50-50, SS9 X 55-50, SS9 X 55-150, SS9 X 1CM-30), they are intended for use in radiology settings and must be handled according to sterile medical device protocols.

Other devices from Biocompatibles, Inc.

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Synthetic Seeding Spacer Model SS9 in a clinical setting?

    The Synthetic Seeding Spacer Model SS9 is designed specifically for brachytherapy procedures to create and maintain consistent spacing between radionuclide seeds during implantation. This ensures even distribution of seeds within the target tissue, which is critical for precise radiation delivery in cancer treatment, particularly in radiology applications.

  • Are these spacers intended for single-use or reusable applications, and how should they be handled?

    The Synthetic Seeding Spacer Model SS9 is a single-use device, though it is supplied in sterile packaging for clinical use. Since they are non-sterile before packaging, they must be handled according to sterile medical device protocols to maintain integrity and prevent contamination during procedures.

  • What sizes are available for the Synthetic Seeding Spacer Model SS9, and how might this affect selection?

    The SS9 is available in four sizes: SS9 X 50-50, SS9 X 55-50, SS9 X 55-150, and SS9 X 1CM-30. These variations allow clinicians to select the appropriate spacer length and configuration based on the specific anatomical or procedural requirements, ensuring optimal seed distribution for the intended radiation therapy.

  • How is the regulatory status of this device determined, and what does that mean for purchasing or use?

    The Synthetic Seeding Spacer Model SS9 was granted FDA 510K clearance in 2010 under the traditional review process, with a determination of substantial equivalence to a predicate device. This means it meets FDA standards for safety and effectiveness as a Class II medical device (regulated under 892.5730) and is approved for use in radiology settings as described in the device’s intended purpose.

  • How should the spacers be stored to ensure they remain suitable for clinical use?

    Since the spacers are supplied in sterile packaging, they should be stored in a clean, dry environment protected from physical damage or contamination. Adherence to manufacturer guidelines for sterile packaging integrity is essential to maintain sterility and usability until the time of use.